ArticleNature2024
Prevalence of persistent SARS-CoV-2 in a large community surveillance study.
Open access · hybridAbstract read
In one paragraph
Article in Nature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers.
0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed
53.7field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
102 citing papers in PubMed, 139 citations in OpenAlex.
- A randomized, double-blind, placebo-controlled trial of niclosamide nanohybrid for the treatment of patients with mild to moderate COVID-19.Nature communications · 2025Trial
- The other immune landscape of SARS-CoV-2 evolution.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- From sites to structure to serology: a roadmap for structure-aware molecular evolution of antigenically evolving viruses.Journal of virology · 2026Review
- Implications of RNA virus persistence for post-acute sequelae and chronic inflammatory syndromes.Nature immunology · 2026Review
- Disentangling the drivers of heterogeneity in SARS-CoV-2 transmission from data on viral load and daily contact rates.PLoS computational biology · 2026Article
- Lower Virulence, Lasting Impact: Cardiovascular Consequences of Hospitalized COVID-19 in the Omicron Era.Circulation. Population health and outcomes · 2026Article
- Building and externally validating a prediction model for long COVID in severe and critical COVID-19 patients: a multi-center cohort study.BMC pulmonary medicine · 2026Observational
- Posterior Circulation Ischemic Stroke Occurring After ChAdOx1 nCoV-19/AZD1222 Vaccination Without Evidence of Vaccine-Induced Immune Thrombotic Thrombocytopenia: A Case Report and Focused Narrative Review.Journal of clinical medicine · 2026Review
- SARS-CoV-2 Delta variant re-emerges in US farmed mink and free-ranging white-tailed deer in 2022-2023.Nature communications · 2026Article
- Large-scale genomic surveillance reveals immunosuppression drives mutation dynamics in persistent SARS-CoV-2 infections.Nature communications · 2026Article
- SARS-CoV-2 Omicron infection reveals imprinted antibody responses in the absence of vaccination.iScience · 2026Article
- SARS-CoV-2 saltational events are recurrent and trace to persistent human infections.bioRxiv : the preprint server for biology · 2026Article
- Characterization of recombinant genomes of the omicron variant of SARS-CoV-2 between 2022 and 2023 in the department of Antioquia, ColombiaBiomedica : revista del Instituto Nacional de Salud · 2026Article
- Acute COVID-19 is associated with altered CD8 T-cells indicative of impaired ability to control Epstein-Barr virus reactivation.Medical microbiology and immunology · 2026Article
- Coordinated immune response distinguishes duration of SARS-CoV-2 viral particle shedding in humans.iScience · 2026Article
- Divergent inflammatory and neurology-related protein levels in long COVID following primary and breakthrough SARS-CoV-2 infections.Communications medicine · 2026Article
- Article
- Disentangling SARS-CoV-2 Sustained Viremia Cases: Evolution, Persistence and Reinfection.Viruses · 2026Article
- Extensive evolution and T cell escape by SARS-CoV-2 in a 2.5-year persistent infection of an immunocompromised host.iScience · 2026Article
- Antibody escape drives emergence of diverse spike haplotypes resembling variants of concern in persistent SARS-CoV-2 infections.Cell reports. Medicine · 2026Article
42 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
36 authors at 9 institutions in 2 countries.
Mahan GhafariBig Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. mahan.ghafari@ndm.ox.ac.uk.ORCID 0000-0002-4123-3287
Matthew HallBig Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID 0000-0002-2671-3864
Tanya GolubchikBig Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID 0000-0003-2765-9828
Daniel AyoubkhaniOffice for National Statistics, Newport, UK.
Thomas HouseDepartment of Mathematics, University of Manchester, Manchester, UK.ORCID 0000-0001-5835-8062
George MacIntyre-CockettBig Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Helen R FryerBig Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Laura ThomsonBig Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Anel NurtayBig Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Steven A KempBig Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID 0000-0001-7077-6793
Luca FerrettiBig Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID 0000-0001-7578-7301
David BuckWellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
Angie GreenWellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
Amy TrebesWellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.ORCID 0000-0002-3715-9109
Paolo PiazzaWellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
Lorne J LonieWellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
Ruth StudleyOffice for National Statistics, Newport, UK.
Emma RourkeOffice for National Statistics, Newport, UK.
Darren L SmithThe Hub for Biotechnology in the Built Environment, Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
Matthew BashtonThe Hub for Biotechnology in the Built Environment, Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.ORCID 0000-0002-6847-1525
Andrew NelsonDepartment of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
Matthew CrownThe Hub for Biotechnology in the Built Environment, Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.ORCID 0000-0002-5091-6282
Clare McCannDepartment of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
Gregory R YoungThe Hub for Biotechnology in the Built Environment, Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.ORCID 0000-0001-5342-1421
Rui Andre Nunes Dos SantosDepartment of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.ORCID 0000-0002-2070-5126
Zack RichardsDepartment of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.ORCID 0000-0002-5392-6558
Mohammad Adnan TariqDepartment of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
Roberto CahuantziOffice for National Statistics, Newport, UK.
Wellcome Sanger Institute COVID-19 Surveillance Team
COVID-19 Infection Survey Group
COVID-19 Genomics UK (COG-UK) Consortium
Jeff BarrettWellcome Sanger Institute, Cambridge, UK.ORCID 0000-0002-1152-370X
Christophe FraserBig Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID 0000-0003-2399-9657
David BonsallBig Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Ann Sarah WalkerNuffield Department of Medicine, University of Oxford, Oxford, UK.
Katrina LythgoeBig Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. katrina.lythgoe@biology.ox.ac.uk.ORCID 0000-0002-7089-7680
Centre for Human Genetics · GBNorthumbria University · GBOpen Data Institute · GBOffice for National Statistics · GBNational Institute for Health Research · GBThe University of Sydney · AUUniversity of Manchester · GBUniversity of Oxford · GBWellcome Sanger Institute · GB
Funding
Medical Research Council MC_PC_19027Wellcome Trust
Abstract
Persistent SARS-CoV-2 infections may act as viral reservoirs that could seed future outbreaks
Indexed as
COVID-19Health SurveysPersistent InfectionSARS-CoV-2Amino Acid SubstitutionAntibodies, MonoclonalEvolution, MolecularHumansImmunocompromised HostMutationPost-Acute COVID-19 SyndromePrevalenceRNA, ViralSelection, GeneticSelf ReportTime FactorsAntibodies, MonoclonalRNA, Viral
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.